Results 191 to 200 of about 70,416 (256)

Lenvatinib versus Sorafenib in First-Line Treatment of Older Patients with Unresectable Hepatocellular Carcinoma: A Subgroup Analysis of the REFLECT Trial. [PDF]

Liver Cancer
Kudo M, Vogel A, Jeffry Evans TR, Ma YT, Daniele B, Baron AD, Mahipal A, Qin S, Blanc JF, Lopez CL, Cheng AL, Choo SP, Piscaglia F, Mody K, Ren M, Chan SL.   +15 more
europepmc   +1 more source

Hepatic Stellate Cells Antagonize Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Upregulating the LINC00152/HSPB1 Axis. [PDF]

Cancers (Basel)
Li Y, Yin J, Fan R, Su J, Yi J, Wang H, Yao B.   +6 more
europepmc   +1 more source

New Chromene Derivatives as Promising VEGFR-2 Inhibitors: Experimental Cytotoxicity and Comprehensive Computational Characterization. [PDF]

Arch Pharm (Weinheim)
Elkady H, Alsfouk AA, Elkaeed EB, Elgammal WE, Mahdy HA, Nofal A, Eissa IH, Husein DZ, Amin FG, Metwaly AM.   +9 more
europepmc   +1 more source

A transcriptomic five-gene signature for sorafenib response prediction in hepatocellular carcinoma: clinical promise and limitations. [PDF]

J Gastrointest Oncol
Reviejo M, Hortelano-Hernandez N, Tizado RE, Briz O, Marin JJG.   +4 more
europepmc   +1 more source

Ferroptosis regulatory networks as therapeutic sensitizers in combination therapy for hepatocellular carcinoma (Review). [PDF]

Oncol Lett
Zhu M, Hu X.
europepmc   +1 more source

LINC01607 promotes hepatocellular carcinoma progression and ferroptosis-associated therapy resistance with functional involvement of the p62-Keap1-Nrf2 pathway. [PDF]

Cancer Drug Resist
Zhang Y, Xu W, Cheng F, Zhu J, Lu Y, Cai G, Li J, Zhang Y.   +7 more
europepmc   +1 more source

Hepatic stellate cells promote structural and functional remodeling of three-dimensional hepatocellular carcinoma coculture spheroids. [PDF]

Mol Biol Rep
Obelar J, Vasconcellos JG, do Nascimento NB, de Sousa AC, Giehl M, Simões Fischer B, de Souza Ferreira J, de Oliveira J, Trindade VMT, Guma FTCR.   +9 more
europepmc   +1 more source

Correction to "Homeobox B13 activates the hypoxia-inducible factor 1 pathway through histone lactylation thereby reprogramming lipid metabolism and promoting sorafenib resistance in hepatocellular carcinoma". [PDF]

J Cell Commun Signal
europepmc   +1 more source

Lidocaine enhances antitumor effects of sorafenib and GW5074 in colorectal cancer cells. [PDF]

J Enzyme Inhib Med Chem
Lin TC, Wu ZS, Huang SM, Liu CW, Hu JM, Wen CC.   +5 more
europepmc   +1 more source

Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: From Targeted Therapy and Combination Strategies to Emerging Therapies. [PDF]

Biomedicines
Li H, Zhou J, Zhu X.
europepmc   +1 more source